Suchergebnisse - (Subject:"Treatment Outcome")

PubPharm (2)

1

First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction

enthalten in: Journal of clinical oncology | February 8, 2016

von Gertz, M. | Landau, H. | Comenzo, R. | +11

2

Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia

enthalten in: Journal of clinical oncology | March 21, 2011

von Hehlmann, R. | Lauseker, M. | Jung-Munkwitz, S. | +17

1
[1]